GABA (Gamma Amino Butyric Acid) Medication for Tobacco

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2007
The goal of this study is to examine the effects of a GABA (gamma amino butyric acid)-enhancing medication, pregabalin (300 mg/day), on smoking behavior, tobacco withdrawal and cigarette craving in smokers. We hypothesize that in smokers, pregabalin at 300 mg/day, will be more effective than placebo in decreasing smoking behavior and attenuating tobacco withdrawal and cigarette craving.
Epistemonikos ID: 516496059e6a1ed2eef3218cc3b6c00a173eee97
First added on: May 04, 2024